News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

John G. F. Cleland, MD

Articles by John G. F. Cleland, MD

High-Versus Low-dose Angiotensin Converting Enzyme Inhibitor Therapy in the Treatment of Heart Failure: An Economic Analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial

ByJ. Sanford Schwartz, MD,Y. Richard Wang, MD, PhD,John G. F. Cleland, MD,Longlong Gao, MS,Mark Weiner, MD,Philip A. Poole-Wilson, MD,fo

June 1st 2003

Latest Updated Articles

High-Versus Low-dose Angiotensin Converting Enzyme Inhibitor Therapy in the Treatment of Heart Failure: An Economic Analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial
Published: June 1st 2003 | Updated:

Trending on AJMC

Single-Tablet Bictegravir/Lenacapavir Effective After Treatment Switch

Chemoradiotherapy Improved Survival in Older Patients With Stage 2 NSCLC

Newly Identified RTEL1 Variant Could Broaden Genetic Landscape of Familial PF

Review Highlights IGHV Testing Complexities in CLL

Non-Invasive Tests Show Promise for Tracking Treatment Response in Semaglutide MASH Trial

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.